Practical Pediatric HematologyAnupam Sachdeva Evidence-based medicine is the need of the hour. Every pediatrician strives for perfection is his or her practice. These are exciting times for Pediatric Hematology and Oncology. Major advances during the past decade in the field have enhanced the understanding and significantly influenced the management and outcome of many of these chronic and fatal diseases affecting children. While opportunities to learn decrease after one leaves the medical school, science keeps evolving. Keeping this in mind, Indian Academy of Pediatrics (IAP) envisaged starting specialty training under its plan of action 2006. Such trainings keep professional and residents updated about newly launched technologies and other advancements. This book is well illustrated and has many pictures and diagrams for the quick understanding of readers. This will be of use not only to the postgraduates of pediatrics but also will be of immense use to a general pediatrician as a ready-reckoner to be kept on the desk. |
From inside the book
Results 1-5 of 64
Page 4
... Serum bilirubin • Lactate dehydrogenase (LDH). Macrocytosis is caused by an increased number of reticulocytes, which have a large cellular volume (140-150 fl) (Fig. 1.1). Anemia with Diminished Reticulocyte Count Bone marrow failure ...
... Serum bilirubin • Lactate dehydrogenase (LDH). Macrocytosis is caused by an increased number of reticulocytes, which have a large cellular volume (140-150 fl) (Fig. 1.1). Anemia with Diminished Reticulocyte Count Bone marrow failure ...
Page 6
... : • Erythropoietin insufficiency18 • Serum inhibitors of erythropoiesis may accumulate in the uremic patients • Hyperparathyroidism may inhibit erythropoiesis by promoting myelofibrosis.19,20 With high 6 Practical Pediatric Hematology.
... : • Erythropoietin insufficiency18 • Serum inhibitors of erythropoiesis may accumulate in the uremic patients • Hyperparathyroidism may inhibit erythropoiesis by promoting myelofibrosis.19,20 With high 6 Practical Pediatric Hematology.
Page 8
... serum ferritin, transferrin saturation, or even serum iron level, some of which can be altered by inflammation or even variation in iron intake.25 Moreover, the increased RDW may be useful in discriminating microcytosis secondary to ...
... serum ferritin, transferrin saturation, or even serum iron level, some of which can be altered by inflammation or even variation in iron intake.25 Moreover, the increased RDW may be useful in discriminating microcytosis secondary to ...
Page 13
... Serum ferritin N D Free erythrocyte N I proporphyrin HbA2 l N/D Abbreviations: D: Decreased; N: Normal; I: Increased REFERENCES 1. 10. 11. 12. 13. 14. Economou-Mavrou C, Tsengli. Interpretation of the Complete Blood Count 13.
... Serum ferritin N D Free erythrocyte N I proporphyrin HbA2 l N/D Abbreviations: D: Decreased; N: Normal; I: Increased REFERENCES 1. 10. 11. 12. 13. 14. Economou-Mavrou C, Tsengli. Interpretation of the Complete Blood Count 13.
Page 14
... Serum erythropoietin levels in patients with congenital heart disease. J Pediatr. 1987; 110:538. 6. Black DB, Lubchenco LO, et al. Developmental and neurologic sequelae of neonatal hyperviscosity syndrome. Pediatr. 1982;69:426. 7 ...
... Serum erythropoietin levels in patients with congenital heart disease. J Pediatr. 1987; 110:538. 6. Black DB, Lubchenco LO, et al. Developmental and neurologic sequelae of neonatal hyperviscosity syndrome. Pediatr. 1982;69:426. 7 ...
Contents
Chapter21 | 156 |
Chapter22 | 165 |
Chapter23 | 178 |
Chapter24 | 181 |
Chapter25 | 199 |
Chapter26 | 208 |
Chapter27 | 232 |
Chapter28 | 247 |
Chapter09 | 69 |
Chapter10 | 75 |
Chapter11 | 85 |
Chapter12 | 90 |
Chapter13 | 97 |
Chapter14 | 115 |
Chapter15 | 120 |
Chapter16 | 125 |
Chapter17 | 130 |
Chapter18 | 144 |
Chapter19 | 148 |
Chapter20 | 153 |
Chapter29 | 259 |
Chapter30 | 262 |
Chapter31 | 266 |
Chapter32 | 272 |
Chapter33 | 281 |
Chapter34 | 289 |
Chapter35 | 298 |
Chapter36 | 305 |
Chapter37 | 309 |
Index | 313 |
Other editions - View all
Common terms and phrases
abnormalities acid activity acute adults antibodies anticoagulant antigen aplastic anemia APTT assay associated bleeding blood loss bone marrow transplantation catheter cause chemotherapy child childhood chronic clinical concentration congenital cytopenia decreased defects develop diagnosis disease disorders Disseminated intravascular coagulation donor dose drugs erythrocyte erythropoietin factor VIII ferritin fetal fibrin fibrinogen folate g/dl gene globin granulocytes Haematol hematocrit hematological hemoglobin hemolysis hemolytic anemia hemophilia hemorrhage heparin hepatitis immune increased India infants infection infusion inhibitor intravenous iron deficiency ischemic laboratory leukemia levels liver malignancy mutations myelodysplastic syndrome myeloid neonatal neutropenia newborn normal nutritional occur oral patients Pediatr peripheral plasma platelet platelet count platelet transfusion present preterm prophylaxis protein prothrombin red cell reticulocyte count risk serum severe splenectomy stem cell stroke studies syndrome Table thalassemia therapy thrombin thrombocytopenia thrombocytosis thrombosis tissue treatment usually venous viral virus vitamin